KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesChange in TaxesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Growth Metrics
Income Statement
Others
Ratios

Co-Diagnostics (CODX) Non-cash Items (2017 - 2025)

Historic Non-cash Items for Co-Diagnostics (CODX) over the last 9 years, with Q3 2025 value amounting to $970570.0.

  • Co-Diagnostics' Non-cash Items fell 672.73% to $970570.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $970570.0, marking a year-over-year decrease of 672.73%. This contributed to the annual value of $1.0 million for FY2024, which is 42028.6% up from last year.
  • As of Q3 2025, Co-Diagnostics' Non-cash Items stood at $970570.0, which was down 672.73% from $970570.0 recorded in Q2 2025.
  • In the past 5 years, Co-Diagnostics' Non-cash Items ranged from a high of $7.6 million in Q4 2021 and a low of $152521.0 during Q2 2024
  • Its 5-year average for Non-cash Items is $1.3 million, with a median of $1.0 million in 2022.
  • Per our database at Business Quant, Co-Diagnostics' Non-cash Items crashed by 8947.37% in 2022 and then soared by 53635.17% in 2025.
  • Over the past 5 years, Co-Diagnostics' Non-cash Items (Quarter) stood at $7.6 million in 2021, then tumbled by 89.47% to $800000.0 in 2022, then crashed by 75.0% to $200000.0 in 2023, then surged by 420.29% to $1.0 million in 2024, then dropped by 6.73% to $970570.0 in 2025.
  • Its Non-cash Items stands at $970570.0 for Q3 2025, versus $970570.0 for Q2 2025 and $970570.0 for Q1 2025.